Glipizide Tablet
Product Images NDC 51655-106

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Glipizide-structure.jpg (Glipizide Structure)
Chemical structure diagram of Glipizide, showing its molecular components including a pyrazine ring, benzene ring, sulfonylurea group, and cyclohexyl group, representing the active ingredient in the Glipizide 10 mg oral tablet by Northwind Health Company, LLC.*
FDA Label Image

Label (51655 106 26 Rev B 06 22 Nhc)

Label (51655 106 26   Rev B 06 22 Nhc)
Label for Glipizide Tablets, USP 10 mg oral tablets by Northwind Health Company, LLC. The package contains 90 tablets with NDC 51655-106-26. The label includes storage instructions at controlled room temperature (20°-25°C) and safety warnings to keep out of reach of children and store in original container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.